Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic …

Purpose A single arm, Phase II trial of carboplatin, nab-paclitaxel, and pembrolizumab (CNP) in metastatic triple negative breast cancer (mTNBC) …

Do you trust this headline?

Based on recent headline ratings, 33% of this readership currently trusts the local media, which has an average score of 71% regionally and is currently trending negative.

33%

Media Trust Score33%